用融合策略提取药物相互作用的多方面的方法
Ba-Hoang Tran1, Hung-Manh Hoang1, Binh-Nguyen Nguyen1
1VNU University of Engineering and Technology, 144 Xuan Thuy, Cau Giay, Hanoi, Viet Nam.
Journal of biomedical informatics
|July 17, 2025
概括
整合各种药物信息,包括文本,图形和图像,显著改善了药物相互作用 (DDI) 检测. 中间融合策略表现最好,提高了患者的安全性和临床决策.
科学领域:
- 药理学和生物信息学 药理学和生物信息学
- 人工智能在医学中的应用
背景情况:
- 药物相互作用 (DDI) 由于药物对疗效的影响而带来风险.
- 目前的DDI研究通常仅依赖文本数据,忽视其他类型的药物信息.
- 需要采用全面的方法来利用多式联络药物数据来改进DDI检测.
研究的目的:
- 通过整合多种药物数据模式来加强药物药物相互作用 (DDI) 提取.
- 评估各种数据融合策略,以优化DDI检测.
- 为模型改进确定影响DDI预测失败的因素.
主要方法:
- 开发了一种多式模式的方法,包括科学文本,图表,公式,图像和描述.
- 探索了早期,中期和晚期的融合技术,以结合模式.
- 在公开的DDI数据集上进行实验,并分析了故障情况.
主要成果:
- 多式联运模型在DDI检测方面显著优于现有方法.
- 中间融合,特别是预测级连接,产生了更高的准确性和稳定性.
- 对失败案例的分析为未来的模型改进提供了洞察力.
结论:
- 多模式融合显著提高了DDI检测的预测准确性.
- 这种方法为更安全的药物治疗和明智的临床决策提供了基础.
- 进一步的研究可以根据已识别的局限性来改进模型.
相关概念视频
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Agonism and Antagonism: Quantification
579
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
579
Combined Effects of Drugs: Antagonism
9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K
Quantitative Aspects of Drug-Receptor Interaction
1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Drug-Receptor Interactions
6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K


